venBio Partners LLC
- SEC CIK
- 0001776382
- Latest filing
- Aug 14, 2026
Holdings in Q1 2024
Holdings as of Mar 31, 2024, filed May 15, 2024. Long positions only; changes compare share counts with Q4 2023.
- Positions
- 5
- −2 vs. Q4 2023
- Portfolio value
- $281.9M
- −$385.3M (−57.8%) vs. Q4 2023
| Security | Class | Shares | Value | % of portfolio | Share change | Action | History |
|---|---|---|---|---|---|---|---|
| ALXOAlx Oncology Holdings Inc | COM | 9,699,925 | $108.2M | 38.4% | 00.0% | Unchanged | History |
| PHVSPharvaris N.V. | COM | 4,289,304 | $99.1M | 35.2% | −630,200−12.8% | Reduced | History |
| HRMYHarmony Biosciences Holdings, Inc. | COM | 1,035,396 | $34.8M | 12.3% | 00.0% | Unchanged | History |
| SLRNACELYRIN, Inc. | COM | 3,852,470 | $26.0M | 9.2% | 00.0% | Unchanged | History |
| ELEVElevation Acquisition Group Inc. | COM | 2,696,133 | $13.8M | 4.9% | −218,122−7.5% | Reduced | History |
Sold out since Q4 2023 (2)
Positions held at the end of Q4 2023 that are gone from this filing.